LYO Cycle Development Ensures Success For Oncology Drug Scale-Up

Scaling a lyophilized oncology drug from lab to large production introduced challenges when excess moisture appeared during validation between drying stages. This indicated that conditions optimized for small-scale equipment did not directly translate to larger systems with different temperature and pressure dynamics. Engineers evaluated existing bench data to understand process behavior and rebalanced the cycle by extending primary drying while reducing secondary drying. The adjusted cycle preserved overall efficiency, adding minimal time while improving moisture removal and product consistency. As a result, the drug achieved a stable, dry state and passed all validation batches without failure. Integrated sterile manufacturing and automated handling further supported quality throughout production. This work demonstrates how data-driven refinement of process conditions can overcome scale-related challenges, ensuring reliable performance, product quality, and readiness for advanced clinical manufacturing at larger volumes.